Logo image of SBFM

SUNSHINE BIOPHARMA INC (SBFM) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:SBFM - US8677817004 - Common Stock

1.24 USD
+0.01 (+0.81%)
Last: 1/26/2026, 4:30:02 PM
1.22 USD
-0.02 (-1.61%)
After Hours: 1/26/2026, 4:30:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
SBFM revenue by date.SBFM revenue by date.
4.346M
1,806.14%
24.093M
454.37%
34.874M
44.75%
38.454M
10.26%
51M
32.63%
EBITDA
YoY % growth
SBFM ebitda by date.SBFM ebitda by date.
-8.649M
-256.17%
-4.636M
46.40%
-5.589M
-20.55%
N/AN/A
EBIT
YoY % growth
SBFM ebit by date.SBFM ebit by date.
-8.674M
-255.35%
-4.785M
44.84%
-5.812M
-21.46%
-4.178M
28.12%
1.734M
141.50%
Operating Margin
SBFM operating margin by date.SBFM operating margin by date.
-199.59%-19.86%-16.67%-10.86%3.40%
EPS
YoY % growth
SBFM eps by date.SBFM eps by date.
N/AN/A-51.88
84.11%
-1.03
98.01%
-0.33
68.32%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25
EPS
Q2Q % growth
-0.28
72.46%
Revenue
Q2Q % growth
10.2M
6.31%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
-1.301M
36.18%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.19
79.79%
-0.13-0.06-43.29%
Q2 2025
Q2Q % growth
-0.39
96.08%
-0.11-0.28-247.59%
Q4 2024
Q2Q % growth
-1.00
99.00%
0.11-1.11-991.27%
Q3 2024
Q2Q % growth
-0.94
98.83%
9.18-10.12-110.24%
Q2 2024
Q2Q % growth
-9.94 -7.55-2.39-31.69%
Q1 2024
Q2Q % growth
-40.00 -21.22-18.78-88.54%
Q4 2023
Q2Q % growth
-100.00 -61.20-38.80-63.40%
Q3 2023
Q2Q % growth
-80.00
-99,900.00%
-122.4042.4034.64%
SBFM Yearly EPS VS EstimatesSBFM Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 -100 -200 -300
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
9.417M
11.64%
11.322M-1.905M-16.82%
Q2 2025
Q2Q % growth
9.41M
1.15%
11.424M-2.014M-17.63%
Q1 2025
Q2Q % growth
8.901M
18.04%
%
Q4 2024
Q2Q % growth
9.595M
24.93%
12.75M-3.155M-24.75%
Q3 2024
Q2Q % growth
8.435M
41.60%
12.036M-3.601M-29.92%
Q2 2024
Q2Q % growth
9.303M
67.29%
9.18M123.07K1.34%
Q1 2024
Q2Q % growth
7.541M
54.08%
7.14M401K5.62%
Q4 2023
Q2Q % growth
7.68M
94.94%
6.222M1.458M23.44%
Q3 2023
Q2Q % growth
5.957M
4,385.69%
6.12M-163K-2.66%
Q2 2023
Q2Q % growth
5.561M
3,599.87%
%
Q1 2023
Q2Q % growth
4.894M
3,888.67%
%
Q4 2022
Q2Q % growth
3.94M
4,529.61%
%
Q3 2022
Q2Q % growth
132.8K
163.49%
%
Q2 2022
Q2Q % growth
150.3K
184.12%
%
Q1 2022
Q2Q % growth
122.7K
205.99%
%
Q4 2021
Q2Q % growth
85.1K
203.93%
%
Q3 2021
Q2Q % growth
50.4K
193.02%
%
Q2 2021
Q2Q % growth
52.9K
248.03%
%
Q1 2021
Q2Q % growth
40.1K
261.26%
%
SBFM Yearly Revenue VS EstimatesSBFM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M 50M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -125% 0% -21.69%
Revenue0% -16.67% 0% -8.96%